# Daniel Weintraub

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/daniel-weintraub/

## Facts

| Field | Value |
| --- | --- |
| Citations | 55,470 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 116 |
| i10-index | 357 |
| Last Known Institution | California University of Pennsylvania |
| OpenAlex ID | https://openalex.org/A5037362183 |
| ORCID iD | https://orcid.org/0000-0003-0633-7168 |
| Works | 624 |

## Researcher papers

Showing 12 of 14.

- [Diagnostic criteria for mild cognitive impairment in Parkinson's disease: <i>Movement</i> Disorder Society Task Force guidelines](https://scholariq.org/papers/diagnostic-criteria-for-mild-cognitive-impairment-in-parkinson-s-disease-i/)
- [Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease](https://scholariq.org/papers/effectiveness-of-atypical-antipsychotic-drugs-in-patients-with-alzheimer-s/)
- [Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy](https://scholariq.org/papers/past-present-and-future-of-parkinson-s-disease-a-special-essay-on-the-200th/)
- [Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study](https://scholariq.org/papers/assessment-of-heterogeneity-among-participants-in-the-parkinson-s-progression/)
- [The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort](https://scholariq.org/papers/the-parkinson-s-progression-markers-initiative-ppmi-establishing-a-pd-biomarker/)
- [A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research](https://scholariq.org/papers/a-biological-definition-of-neuronal-synuclein-disease-towards-an-integrated/)
- [Effect of Citalopram on Agitation in Alzheimer Disease](https://scholariq.org/papers/effect-of-citalopram-on-agitation-in-alzheimer-disease/)
- [Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals](https://scholariq.org/papers/levodopa-dose-equivalency-in-parkinson-s-disease-updated-systematic-review-and/)
- [Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease](https://scholariq.org/papers/cognitive-performance-and-neuropsychiatric-symptoms-in-early-untreated-parkinson/)
- [Longitudinal study of normal cognition in Parkinson disease](https://scholariq.org/papers/longitudinal-study-of-normal-cognition-in-parkinson-disease/)
- [Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group](https://scholariq.org/papers/cognitive-impairment-in-multiple-system-atrophy-a-position-statement-by-the/)
- [Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort](https://scholariq.org/papers/longitudinal-change-of-clinical-and-biological-measures-in-early-parkinson-s/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Balance, Gait, and Falls Prevention](https://scholariq.org/topics/balance-gait-and-falls-prevention/)

## Researcher university

- [California University of Pennsylvania](https://scholariq.org/institutions/california-university-of-pennsylvania/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.